4.7 Article

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms

Rong En Tay et al.

Summary: Cancer immunotherapy has transformed cancer treatment, with immune checkpoint blockade therapy and adoptive cell therapy becoming standard care for many cancer types. Recent evidence suggests that CD4(+)T cells play a significant role in the anti-tumour immune response, highlighting their potential importance in cancer immunotherapies.

CANCER GENE THERAPY (2021)

Article Oncology

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018

Seri Hong et al.

Summary: The study presents national cancer statistics and trends in Korea for 2018, covering incidence, mortality, survival, and prevalence rates. Overall, cancer incidence rates increased annually by 3.3% from 1999 to 2012, then decreased by 5.4% annually from 2012 to 2015, followed by insignificant changes. Meanwhile, cancer mortality rates have been decreasing since 2002, with a more rapid decline in recent years.

CANCER RESEARCH AND TREATMENT (2021)

Review Cell Biology

Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy

Ji Woong Kim et al.

Summary: GRP94, a member of the HSP90 family, plays a vital role in regulating biological functions under physiological conditions, but its overexpression in several cancers has been shown to promote disease progression and metastasis. This review highlights the physiological and pathological roles of GRP94 in normal and cancer cells, and discusses the potential of targeting it as a therapeutic approach.

CELLS (2021)

Review Oncology

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target

Xiaofeng Duan et al.

Summary: GRP94 plays a crucial role in tumor development by promoting survival signals, modulating immune responses, and correlating with aggressive phenotypes and poor clinical outcomes. It has the potential to be a therapeutic target in malignancies.

FRONTIERS IN ONCOLOGY (2021)

Article Pathology

Prognostic significance of glucose-related protein 94 in colorectal cancer

Jae Seok Lee et al.

PATHOLOGY RESEARCH AND PRACTICE (2020)

Review Pathology

Tumor immune response and immunotherapy in gastric cancer

Yoonjin Kwak et al.

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)

Article Biotechnology & Applied Microbiology

Glucose-Regulated Protein 94 Modulates the Response of Osteosarcoma to Chemotherapy

Chien-Yu Huang et al.

DISEASE MARKERS (2019)

Article Medicine, Research & Experimental

Glucose-regulated protein of 94 kDa contributes to the development of an aggressive phenotype in breast cancer cells

Pedro Buc Calderon et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Biochemistry & Molecular Biology

CD4 and CD8 T lymphocyte interplay in controlling tumor growth

Dmitrij Ostroumov et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Gastroenterology & Hepatology

Global patterns and trends in colorectal cancer incidence and mortality

Melina Arnold et al.

Review Biochemistry & Molecular Biology

Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer

Juan R. Cubillos-Ruiz et al.

Review Chemistry, Medicinal

Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94

Ephraim A. Ansa-Addo et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)

Article Medicine, Research & Experimental

Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer

Deborah Ryan et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2016)

Review Pathology

The Role of Endoplasmic Reticulum Stress in Human Pathology

Scott A. Oakes et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)

Article Medicine, Research & Experimental

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma

F Sabbatino et al.

Journal of Translational Medicine (2015)

Review Biochemistry & Molecular Biology

Endoplasmic reticulum stress associated responses in cancer

Wen-An Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)